Package 70121-1743-4

Brand: nelarabine

Generic: nelarabine
NDC Package

Package Facts

Identity

Package NDC 70121-1743-4
Digits Only 7012117434
Product NDC 70121-1743
Product ID 70121-1743_2a0e02cf-dd3d-4fb6-b9a3-dc29d1156c28
Description

6 VIAL, SINGLE-DOSE in 1 CARTON (70121-1743-4) / 50 mL in 1 VIAL, SINGLE-DOSE (70121-1743-1)

Marketing

Marketing Status
Marketed Since 2023-04-10
Brand nelarabine
Generic nelarabine
Sample Package No

Linked Drug Pages (1)

Nelarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2a0e02cf-dd3d-4fb6-b9a3-dc29d1156c28", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0370121174318"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["8d0e1b59-bd1e-4c6e-9a95-e8143ee076bf"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 VIAL, SINGLE-DOSE in 1 CARTON (70121-1743-4)  / 50 mL in 1 VIAL, SINGLE-DOSE (70121-1743-1)", "package_ndc": "70121-1743-4", "marketing_start_date": "20230410"}], "brand_name": "Nelarabine", "product_id": "70121-1743_2a0e02cf-dd3d-4fb6-b9a3-dc29d1156c28", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "70121-1743", "generic_name": "Nelarabine", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nelarabine", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA216346", "marketing_category": "ANDA", "marketing_start_date": "20230410", "listing_expiration_date": "20261231"}